External Qi of Yan Xin Qigong differentially regulates the Akt and extracellular signal-regulated kinase pathways and is cytotoxic to cancer cells but not to normal cells

International Journal of Biochemistry and Cell Biology

Volumn 38, Issue 12, 2006, Pages 2102-2113

  Yan, Xin ^a,b   Shen, Hua ^b   Jiang, Hongjian ^c   Zhang, Chengsheng ^d   Hu, Dan ^d   Wang, Jun ^b   Wu, Xinqi ^e  

^a Chongqing Institute of Traditional Chinese Medicine   (China)

^b New Medical Science Research Institute   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Akt; ERK1 2; External Qi; Pancreatic cancer; Yan Xin Qigong

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; DNA FRAGMENT; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; PROTEIN KINASE B;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL ACTIVITY; CELL CYCLE G1 PHASE; CELL POPULATION; CELL SURVIVAL; CHINESE MEDICINE; CHRONOTHERAPY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXTRACELLULAR SPACE; FIBROBLAST; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PANCREAS CANCER; PROTEIN DEGRADATION; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BREATHING EXERCISES; CELL DEATH; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; PANCREATIC NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; QI; SIGNAL TRANSDUCTION;

EID: 33748691348     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2006.06.002     Document Type: Article

References (63)

1. Arlt A., Gehrz A., Muerkoster S., Vorndamm J., Kruse M.L., Folsch U.R., et al. Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene 22 (2003) 3243-3251
2. Arlt A., Vorndamm J., Breitenbroich M., Folsch U.R., Kalthoff H., Schmidt W.E., et al. Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin. Oncogene 20 (2001) 859-868
3. Arlt A., Vorndamm J., Muerkoster S., Yu H., Schmidt W.E., Folsch U.R., et al. Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresi stance in pancreatic carcinoma cell lines. Cancer Research 62 (2002) 910-916
4. Asano T., Yao Y., Zhu J., Li D., Abbruzzese J.L., and Reddy S.A. The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells. Oncogene 23 (2004) 8571-8580
5. Ashush H., Rozenszajn L.A., Blass M., Barda-Saad M., Azimov D., Radnay J., et al. Apoptosis induction of human myeloid leukemic cells by ultrasound exposure. Cancer Research 60 (2000) 1014-1020
6. Bondar V.M., Sweeney-Gotsch B., Andreeff M., Mills G.B., and McConkey D.J. Inhibition of the phosphatidylinositol 3′-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo. Molecular Cancer Therapeutics 1 (2002) 989-997
7. Boonstra J., Rijken P., Humbel B., Cremers F., Verkleij A., van Bergen E., et al. The epidermal growth factor. Cell Biology International 19 (1995) 413-431
8. Boucher M.J., Morisset J., Vachon P.H., Reed J.C., Laine J., and Rivard N. MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells. Journal of Cellular Biochemistry 79 (2000) 355-369
9. Bruns C.J., Solorzano C.C., Harbison M.T., Ozawa S., Tsan R., Fan D., et al. Blockade of epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. Cancer Research 60 (2000) 2926-2935
10. Budihardjo I., Oliver H., Lutter M., Luo X., and Wang X. Biochemical pathways of caspase activation during apoptosis. Annual Review of Cell and Developmental Biology 15 (1999) 269-290
11. Cantly L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
12. Chang F., Steelman L.S., Shelton J.G., Lee J.T., Navolanic P.M., Blalock W.L., et al. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway. International Journal of Oncology 22 (2003) 469-480
13. Chen K.W. An analytic review of studies on measuring effects of external Qi in China. Alternative Therapies in Health and Medicine 10 (2004) 38-50
14. Datta S.R., Brunet A., and Geenberg M.E. Cellular survival: a play in three Akts. Genes & Development 13 (1999) 2905-2927
15. Dhar A., Mehta S., Banerjee S., Dhar K., Dhar G., Sengupta K., et al. Epidermal growth factor receptor: is a novel therapeutic target for pancreatic cancer?. Frontiers in Bioscience 10 (2005) 1763-1767
16. Dong Q.G., Sclabas G.M., Fujioka S., Schmidt C., Peng B., Wu T., et al. The function of multiple IkappaB: NF-kappa B complexes in the resistance of cancer cells to Taxol-induced apoptosis. Oncogene 21 (2002) 6510-6519
17. Elnemr A., Ohta T., Yachie A., Kayahara M., Kitagawa H., Ninomiya I., et al. Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape. International Journal of Oncology 18 (2001) 33-39
18. Fang J.Y., and Richardson B.C. The MAPK signaling pathways and colorectal cancer. Lancet Oncology 6 (2005) 322-327
19. Feigl T., Volklein B., Iro H., Ell C., and Schneider T. Biophysical effects of high-energy pulsed ultrasound on human cells. Ultrasound in Medicine & Biology 22 (1996) 1267-1275
20. Feng J., Adsay N.V., Kruger M., Ellis K.L., Nagothu K., Majumdar A.P., et al. Expression of ERRP in normal and neoplastic pancreata and its relationship to clinicopathologic parameters in pancreatic adenocarcinoma. Pancreas 25 (2002) 342-349
21. Fong Y.H. Yan Xin Qigong informative product: Qi nutrition powder. In: International Yan Xin Qigong Association (Ed). Yan Xin Qigong collectanea Vol. 6 (1997), Les Editions LOTUS Publishers of Canada, Quebec 299-318
22. Garcea G., Neal C.P., Pattenden C.J., Steward W.P., and Berry D.P. Molecular prognostic markers in pancreatic cancer: A systematic review. European Journal of Cancer 41 (2005) 2213-2236
23. Greenlee R.T., Hill-Harmon M.B., Murray T., and Thun M. Cancer statistics. CA: A Journal for Clinicians 51 (2001) 15-36
24. Kalthoff H., Schmiegel W., Roeder C., Kasche D., Schmidt A., Lauer G., et al. p53 and K-RAS alterations in pancreatic epithelial cell lesions. Oncogene 8 (1993) 289-298
25. Lejbkowicz F., Zwiran M., and Salzberg S. The response of normal and malignant cells to ultrasound in vitro. Ultrasound in Medicine & Biology 19 (1993) 75-82
26. Li S., Sun M., Dai Z., Zhang P., Meng G., Liu Z., et al. Experimental studies on the feasibility of improving industrial strains with external Qi treatment. Nature Journal 13 (1990) 791-801
27. Lockhart A.C., Rothenberg M.L., and Berlin J.D. Treatment for pancreatic cancer: Current therapy and continued progress. Gastroenterology 128 (2005) 1642-1654
28. Lu Z. Scientific Qigong exploration-The wonders and mysteries of Qi (1997), Amber Leaf Press, Malvern, PA
29. Matsuda K., Idezawa T., You X.J., Kothari N.H., Fan H., and Korc M. Multiple mitogenic pathways in pancreatic cancer cells are blocked by a truncated epidermal growth factor receptor. Cancer Research 62 (2002) 5611-5617
30. Ming Z. The new frontiers of modern sciences-An introduction to YanXin Qigong (1988), Xinhua Press, Beijing
31. Moore P.S., Sipos B., Orlandini S., Sorio C., Real F.X., Lemoine N.R., et al. Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4. Virchows Archiv 439 (2001) 798-802
32. Murphy L.O., Cluck M.W., Lovas S., Otvos F., Murphy R.F., Schally A.V., et al. Pancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions. British Journal of Cancer 84 (2001) 926-935
33. Ng S.S., Tsao M.S., Chow S., and Hedley D.W. Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells. Cancer Research 60 (2000) 5451-5455
34. Nicholson K.M., and Anderson N.G. The protein kinase B/Akt signaling pathway in human malignancy. Cell Signaling 14 (2002) 381-395
35. Ozes O.N., Mayo L.D., Gustin J.A., Pfeffer S.R., Pfeffer L.M., and Donner D.B. NF-κB activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature 401 (1999) 86-90
36. Perugini R.A., McDade T.P., Vittimberga F.J., and Callery M.P. Pancreatic cancer cell proliferation is phosphatidylinositol 3-kinase dependent. Journal of Surgical Research 90 (2000) 39-44
37. Proskuryakov S.Y., Konoplyannikov A.G., and Gabai V.L. Necrosis: A specific form of programmed cell death?. Experimental Cell Research 283 (2003) 1-16
38. Radeva M., and Berg H. Differences in lethality between cancer cells and human lymphocytes caused by LF-electromagnetic fields. Bioelectromagnetics 25 (2004) 503-507
39. Richards D.A. Chemotherapeutic gemcitabine doublets in pancreatic carcinoma. Seminars in Oncology 32 Suppl. 6 (2005) 9-13
40. Seki K., Chisaka M., Eriguchi M., Yanagie H., Hisa T., Osada I., et al. An attempt to integrate Western and Chinese medicine: rationale for applying Chinese medicine as chronotherapy against cancer. Biomedicine & Pharmacotherapy 59 (2005) S132-S140
41. Shi X., Liu S., Kleeff J., Friess H., and Buchler M.W. Acquired resistance of pancreatic cancer cells towards 5-Fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes. Oncology 62 (2002) 354-362
42. Song G., Ouyang G., and Bao S. The activation of Akt/PKB signaling pathway and cell survival. Journal of Cellular and Molecular Medicine 9 (2005) 59-71
43. Tachibana K., Uchida T., Hisano S., and Morioka E. Eliminating adult T-cell leukemia cells with ultrasound. The Lancet 349 (1997) 325
44. Tang B., Li L., Jiang Z., Luan Y., Li D., Zhang W., et al. Characterization of the mechanisms of electrochemotherapy in an in vitro model for human cervical cancer. International Journal of Oncology 26 (2005) 703-711
45. Wang R., and Zhu R. Yan Xin Qigong nutrition powder: Nine case report. In: International Yan Xin Qigong Association (Ed). Yan Xin Qigong collectanea Vol. 1 (1997), Les Editions LOTUS Publishers of Canada, Quebec 266-271
46. Xiong H.Q. Molecular targeting therapy for pancreatic cancer. Cancer Chemotherapy and Pharmacology 54 Suppl. 1 (2004) 69-77
47. Yan X., Fong Y.H., Jiang H., Zhang C., Hu D., Shen H., et al. Yan Xin Qigong external Qi Yan Xin Qigong information water and XY-S exhibit potent and selective cytotoxic effects on human cancer cells independently of p53 status but have no cytotoxicity to normal cells [Abstract]. Asian Journal of Surgery 26 Suppl. 1 (2002) 45
48. Yan X., Fong Y.H., Wolf G., Wolf D., and Cao W. Protective effect of XY99-[5038] on hydrogen peroxide induced cell death in cultured retinal neurons. Life Sciences 69 (2001) 289-299
49. Yan X., Fong Y.H., Wolf G., Zaharia M., Wolf D., Brackett D.J., et al. XY99-5038 promotes long-term survival of cultured retinal neurons. International Journal of Neuroscience 112 (2002) 1209-1227
50. Yan X., Li S., Liu C., Hu J., Mao S., and Lu Z. The observation of the effect of external Qi on synthesis gas system. Nature Journal 11 (1988) 650-652
51. Yan X., Li S., Yang Z., and Lu Z. Observation on the bromination reaction in solution of n-hexane and bromine under the influence of external Qi. Nature Journal 11 (1988) 653-655
52. Yan X., Li S., Yu J., Li B., and Lu Z. Laser Raman observation on tap water, saline, glucose and medemycine solutions under the influence of external Qi. Nature Journal 11 (1988) 567-571
53. Yan X., Lin H., Li H., Traynor-Kaplan A., Xia Z., Lu F., et al. Structural and property changes in certain materials influenced by the external Qi of Qigong. Materials Research Innovations 2 (1999) 349-359
54. Yan X., Lu F., Jiang H., Wu X., Cao W., Xia Z., et al. Certain manifestation and effects of external Qi of Yan Xin life science technology. Journal of Scientific Exploration 16 (2002) 381-411
55. Yan X., Shen H., Zaharia M., Wang J., Wolf D., Li F., et al. Involvement of phosphatidylinositol 3-kinase and insulin-like growth factor-I in YXLST-mediated neuroprotection. Brain Research 1006 (2004) 198-206
56. Yan X., Xia Z.Q., Shen H., and Traynor-Kaplan A. External Qi of Yan Xin life science and technology can revive or suppress enzyme activity of 28 phosphatidylinositol 3-kinase. Bulletin of Science, Technology & Society 22 (2002) 403-406
57. Yan X., Zhao N., Yin C., and Lu Z. The effect of external Qi on liposome phase behavior. Nature Journal 11 (1988) 572-576
58. Yan X., Zheng C., Zou G., and Lu Z. Observations of the effects of external Qi on the ultraviolet absorption of nucleic acids. Nature Journal 11 (1988) 647-649
59. Yao R., and Cooper G.M. Requirment for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267 (1995) 2003-2006
60. Yen Y., Li J.-R., Zhou B.-S., Rojas F., Yu J., and Chou C.K. Electrochemical treatment of human KB cells in vitro. Bioelectromagnetics 20 (1999) 34-41
61. Yip-Schneider M.T., Wiesenauer C.A., and Schmidt C.M. Inhibition of the phosphatidylinositol 3-kinase signaling pathway increases the responsiveness of pancreatic carcinoma cells to sulindac. Journal of Gastrointestinal Surgery 7 (2003) 354-363
62. Zhang Y., Banerjee S., Wang Z.W., Marciniak D.J., Majumdar A.P., and Sarkar F.H. Epidermal growth factor receptor-related protein inhibits cell growth and induces apoptosis of BxPC3 pancreatic cancer cells. Cancer Research 65 (2005) 3877-3882
63. Zhang Z.W., Zhao J.X., and Zhang X.R. Yan Xin Qigong nutrition powder: Clinical report. In: International Yan Xin Qigong Association (Ed). Yan Xin Qigong collectanea Vol. 1 (1997), Les Editions LOTUS Publishers of Canada, Quebec 319-329